Difference between revisions of "Aminopterin"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Investigational" to "Category:Investigational drugs") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Discontinued" to "Category:Discontinued drugs") |
||
| Line 15: | Line 15: | ||
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
| − | [[Category:Discontinued]] | + | [[Category:Discontinued drugs]] |
Revision as of 17:47, 3 February 2019
General information
Class/mechanism: Folate analog, antimetabolite, interferes with DNA synthesis. Discontinued due to concerns about toxicity, manufacturing difficulties, and rough equivalence to methotrexate. It remains under investigation for the non-neoplastic condition of psoriasis.
Route: IM